Qnexa’s Second Chance

September 15th, 2011 by MorganDowney Leave a reply »

Vivus Inc. has indicated that the FDA will accept a resubmission of the application and hold a second Advisory Committee on Qnexa in early 2012. Early indications are the revisions would indicate a label for men and women of non-childbearing age.VIVUS, Inc. – VIVUS Provides Regulatory Update on QNEXA